This week, on the precipice of a historic U.S. election I will start with a brief commentary on making portfolio decisions based on election outcomes.
Back by popular demand we have decided to make our new Case For, Case Against segment a permanent fixture. Our head of income research, Mr. Aaron Dunn will make his highly anticipated first argument facing off against Brennan. In the line of fire is Apple Inc. (AAPL: NASDAQ), the iPhone company which should need no introduction. While the stock sold off this week after its quarterly results included a lack of forward guidance, the consumer tech giant is up 47% this year. We argue both sides of the BUY/SELL argument for the stock.
With a hat tip to Movember and men’s cancer prevention and treatment, this week’s Your Stock, Our Take was sent in from a listener on Profound Medical Corp. (PRN: TSX), a medical technology company developing medical treatments with its core technology used to ablate the prostate gland. We let you know if the share price gains are justifiable based on the underlying cash flow at present.
Stock Talk Podcast Episode 95
Stock Talk Podcast Episode 94
Stock Talk Podcast Episode 93
Stock Talk Podcast Episode 92
Stock Talk Podcast Episode 91
Stock Talk Podcast Episode 90
Stock Talk Podcast Episode 89
Stock Talk Podcast Episode 88
Stock Talk Podcast Episode 87
Stock Talk Podcast Episode 86
Stock Talk Podcast Episode 85
Stock Talk Podcast Episode 84
Stock Talk Podcast Episode 83
Stock Talk Podcast Episode 82
Stock Talk Podcast Episode 81
Stock Talk Podcast Episode 80
Stock Talk Podcast Episode 79
Stock Talk Podcast Episode 78
Stock Talk Podcast Episode 77
Stock Talk Podcast Episode 76
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
U.S Property Podcast
Aligned Money Show
Dubai Property Podcast
The Ramsey Show
The Clark Howard Podcast